HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D A Westerman Selected Research

Lymphoma (Lymphomas)

8/2014Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.
12/2010Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D A Westerman Research Topics

Disease

2Neoplasms (Cancer)
10/2018 - 08/2014
2Lymphoma (Lymphomas)
08/2014 - 12/2010
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2010 - 02/2009
1Pain (Aches)
08/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2010

Drug/Important Bio-Agent (IBA)

2fludarabineIBA
12/2010 - 02/2009
1pegfilgrastim (Neulasta)FDA Link
08/2014
1plerixaforFDA Link
08/2014
1Filgrastim (Neupogen)FDA Link
02/2009
1Stem Cell FactorIBA
02/2009

Therapy/Procedure

2Therapeutics
10/2018 - 12/2010
1Blood Component Removal (Apheresis)
08/2014
1Aftercare (After-Treatment)
12/2010
1Combination Drug Therapy (Combination Chemotherapy)
12/2010